Search results

Selected filters:

Transactions

Article type

Topic

Sector

Regions

3,950 results found for your search

Sort options
16 October 2019

Tencent dips back into patent market with third IBM deal

Chinese internet giant faces NPE litigation in the US and upstart Chinese rivals that are getting smart on patents

14 October 2019

A shift in focus at Microsoft sees part of its IP team head for the exit

Licensing specialists are understood to have been most affected in a round of departures which come a year after the company joined LOT Network and OIN

11 October 2019

Fractus expands litigation campaign to Delhi

European developer of antenna tech opened up a new front against Chinese smartphone companies in India earlier this year. Unlicensed brands have taken over a larger share of India's smartphone market in recent years

10 October 2019

Shenzhen government to launch China’s latest IP fund

But the details suggest authorities understand limitations of IP subsidies and financialisation

09 October 2019

IBM has the world's most valuable patent portfolio, new analysis claims

Samsung, Canon, Microsoft and Bosch round-out the top five who, between them, are said to own assets worth well in excess of $35 billion

08 October 2019

Patent commercialisation when you have 300 CEOs

Senior executives from CalTech, Stanford, Battelle and Rambus share their thoughts on the changing state of play in tech transfer

04 October 2019

The new China dynamic, pool progress and more from our Patent Licensing event

The big takeaways from a day of deal-making discussions in the heart of Silicon Valley

04 October 2019

KT Corp lines up corporate patent sales with Samsung the latest customer

Korean telco has started selling patents to other operating companies in the last two years, after previous deals focused on the NPE sector

03 October 2019

For start-ups, patents should be a means to an end, not an end in themselves

Investing in IP may be necessary for early-stage businesses, but there are plenty of circumstances when the money is better spent elsewhere

01 October 2019

The top biopharma patent stories in September

Our round-up of all the major IP developments affecting the life sciences industries last month

30 September 2019

ITRI spin-out is plaintiff in latest genomics patent campaign

Taiwan’s Personal Genomics is going after an acquisition target of Illumina, the top player in the sequencing space

27 September 2019

Before IBM arrived, building a patent deterrent meant plenty of deals for Red Hat

In an exclusive interview, the company's IP head reveals that in the run-up to its acquisition by Big Blue the open source leader went shopping at a range of companies include AT&T, Huawei and Panasonic

24 September 2019

Sony worries company split would lead to higher IP fees

Concern about parting with its image sensor business and IP portfolio illustrates a problem for Japanese companies seeking to restructure

21 September 2019

Huawei’s 5G spinoff bluff shows why export ban will hurt US tech firms

CEO Ren Zhengfei doesn’t think another company can build a business around Huawei’s 5G technology stack. Not only will the company's predicament not help US tech firms, it is actively hurting them

20 September 2019

Territory, not technology, is Alibaba’s biggest challenge

The Jack Ma era has come to an end at the Chinese giant, leaving his successor to leverage the company’s data and services to establish a strong presence in the APAC region